Negotiations Begin Between Bristol-Myers Squibb and ImClone

By Taskin Ahmed

Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)

Published: 1 Aug-2008

DOI: 10.3833/pdr.v2008.i99.150     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Bristol-Myers Squibb has offered to buy the remaining shares of ImClone for US$4...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details